株探米国株
日本語 英語
エドガーで原本を確認する
0000785786false00007857862024-04-242024-04-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
____________________________________________________________________________________________________________________________________
Date of Report (Date of earliest event reported): April 24, 2024
____________________________________________________________________________________________________________________________________
plxslogo8ka05.gif
PLEXUS CORP.
(Exact name of registrant as specified in its charter)
____________________________________________________________________________________________________________________________________
Wisconsin 001-14423 39-1344447
(State or other jurisdiction
 of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
One Plexus Way
Neenah, Wisconsin 54957
(Address of principal executive offices) (Zip Code)
Telephone Number (920) 969-6000
(Registrant’s telephone number, including Area Code) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, $0.01 par value PLXS The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
        If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐



Item 2.02    Results of Operations and Financial Condition.

On April 24, 2024, Plexus Corp. (“we” or the “Company”) announced results for the fiscal second quarter ended March 30, 2024. A copy of the Company’s related press release is furnished as Exhibit 99.1 to this report.


Item 9.01    Financial Statements and Exhibits

(d) The following exhibits are filed herewith:

Exhibit Number Description
99.1
104 Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document)





* * * * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: April 24, 2024 PLEXUS CORP.
(Registrant)
By: /s/ Patrick J. Jermain
Patrick J. Jermain
Executive Vice President and Chief Financial Officer


EX-99.1 2 plxsf24q2earningsreleasexe.htm EX-99.1 Document

plexusprlogo_1a.gif
Plexus Announces Fiscal Second Quarter Financial Results
NEENAH, WI – April 24, 2024 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended March 30, 2024, and guidance for our fiscal third quarter ending June 29, 2024.
•Reports fiscal second quarter 2024 revenue of $967 million, GAAP operating margin of 3.0% and GAAP diluted EPS of $0.58, including $0.25 of stock-based compensation expense and $0.36 of restructuring and other charges, net
•Reports fiscal second quarter 2024 non-GAAP operating margin of 4.2% and non-GAAP diluted EPS of $0.94, including $0.25 of stock-based compensation expense
•Initiates fiscal third quarter 2024 revenue guidance of $960 million to $1.00 billion with GAAP diluted EPS of $0.80 to $0.95, including $0.21 of stock-based compensation expense and $0.21 of restructuring charges. Fiscal third quarter 2024 non-GAAP EPS guidance of $1.22 to $1.37 excludes both stock-based compensation expense and restructuring charges.
Three Months Ended
Mar 30, 2024 Mar 30, 2024 Jun 29, 2024
Q2F24 Results
Q2F24 Guidance
Q3F24 Guidance (1)
Summary GAAP Items
Revenue (in millions) $967 $930 to $970 $960 to $1,000
Operating margin (2) 3.0  % 3.0% to 3.4% 3.9% to 4.3%
Diluted EPS (3) $0.58 $0.48 to $0.63 $0.80 to $0.95
Summary Non-GAAP Items (4)
Adjusted operating margin (5) 4.2  % 4.0% to 4.4%
Adjusted EPS (6) $0.94 $0.80 to $0.95
Adjusted operating margin, prospectively (7) 5.2% to 5.6%
Adjusted EPS, prospectively (8) $1.22 to $1.37
Return on invested capital (ROIC) 9.9  %
Economic return 1.7  %
(1) Historically, Plexus has included stock-based compensation expense in adjusted operating margin and adjusted EPS. Beginning in the fiscal third quarter, Plexus will issue guidance and present adjusted operating margin and adjusted EPS excluding stock-based compensation expense. Refer to the Non-GAAP Supplemental Information Table 3 for a reconciliation between the historic presentation and prospective presentation.
(2) Includes restructuring and other charges, net, of 120 bps for Q2F24 results, 100 bps for Q2F24 guidance and 70 bps for Q3F24 guidance. Includes stock-based compensation expense of 73 bps for Q2F24 results, 72 bps for Q2F24 guidance, and 60 bps for Q3F24 guidance.
(3)
Includes stock-based compensation expense of $0.25 for Q2F24 results, $0.25 for Q2F24 guidance and $0.21 for Q3F24 guidance. Includes, net of tax, restructuring and other charges, net, of $0.36 for Q2F24 results, $0.32 for Q2F24 guidance, and $0.21 for Q3F24 guidance.
(4) Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for additional information regarding non-GAAP financial measures.
(5) Excludes restructuring and other charges, net, of 120 bps for Q2F24 results and 100 bps for Q2F24 guidance. Excludes stock-based compensation expense of 73 bps for Q2F24 results and 72 bps for Q2F24 guidance.
(6)
Q2F24 results excludes, net of tax, $0.36 per share related to restructuring and other charges, net, but includes stock-based compensation expense of $0.25. Q2F24 guidance excludes $0.32 per share related to restructuring and other charges, net, but includes stock-based compensation expense of $0.25.
(7) Excludes 70 bps for restructuring charges and 60 bps related to stock-based compensation expense.
(8) Excludes $0.21 per share related to restructuring charges and $0.21 per share related to stock-based compensation expense.





Fiscal Second Quarter 2024 Information
•Won 32 manufacturing programs during the quarter representing $255 million in annualized revenue when fully ramped into production.
•Purchased $17.6 million of our shares at an average price of $94.39 per share under our repurchase programs, leaving $38.1 million available under our current $50.0 million authorization.

Todd Kelsey, Chief Executive Officer, commented, “Plexus delivered fiscal second quarter revenue of $967 million and non-GAAP EPS of $0.94, each of which met the top end of our guidance. Non-GAAP operating margin of 4.2% met our expectation entering the quarter. In addition, we generated free cash flow of $65 million, a particularly strong result.”

Mr. Kelsey continued, “For the fiscal second quarter, our team won 32 new manufacturing programs worth $255 million in annualized revenue. Capitalizing on the value created by our differentiated service offering and superior execution, our go-to-market organization is winning significant new outsourcing opportunities and capturing market share in support of sustaining our industry-leading revenue growth.”

Mr. Kelsey commented, “We are guiding fiscal third quarter revenue of $960 million to $1.00 billion, non-GAAP operating margin of 5.2% to 5.6% and non-GAAP EPS of $1.22 to $1.37. We believe our revenue growth is in the early stages of inflecting higher, benefiting from robust demand within our Aerospace and Defense market sector, gradually recovering semiconductor capital equipment demand and new program ramps that are mitigating inventory correction headwinds in our Healthcare/Lifesciences and Industrial market sectors. For the fiscal third quarter, our non-GAAP operating margin excludes approximately $6.5 million of restructuring charges associated with realigning manufacturing capabilities to best support long-term customer needs and also excludes approximately $6.2 million of stock-based compensation expense.”

Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, “The $65 million of free cash flow generated during the fiscal second quarter significantly exceeded our net income and our expectations. Continued progress on our working capital initiatives contributed to this strong performance, resulting in fiscal second quarter cash cycle of 91 days, 10 days favorable to our expectations and sequentially lower by four days. Aided by the improvements in our cash cycle, return on invested capital for the fiscal second quarter was 9.9%, or 170 basis points above our weighted average cost of capital. We have generated $33 million of free cash flow through the first six months of fiscal 2024 and, with further progress expected on our working capital initiatives, we now anticipate delivering approximately $100 million of free cash flow in fiscal 2024. Finally, we repurchased $17.6 million of our shares during the fiscal second quarter. We expect to execute the remaining $38.1 million of our current authorization during the second half of fiscal 2024, creating additional shareholder value.”

Mr. Kelsey concluded, “We continue to anticipate a strong finish to fiscal 2024 with expansion in revenue and non-GAAP operating margin each quarter as well as robust free cash flow generation, positioning us for further momentum into fiscal 2025. Supporting this outlook is the previously highlighted strength in certain market sectors and subsectors, new program ramps, improving utilization of our engineering team and the benefits from recent restructuring actions.”
2


Quarterly Comparison Three Months Ended
(in thousands, except EPS) Mar 30, 2024 Dec 30, 2023 Apr 1, 2023
Revenue $ 966,900  $ 982,607  $ 1,070,823 
Gross profit 88,063  88,140  102,993 
Operating income 29,470  45,158  56,942 
Net income 16,239  29,215  40,844 
Diluted EPS $ 0.58  $ 1.04  $ 1.45 
Gross margin 9.1  % 9.0  % 9.6  %
Operating margin 3.0  % 4.6  % 5.3  %
ROIC (1) 9.9  % 10.3  % 13.8  %
Economic return (1) 1.7  % 2.1  % 4.8  %
(1) Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised 48% of revenue during both the first and second quarter of fiscal 2024. This is down three percentage points from the second quarter of fiscal 2023.

Business Segments ($ in millions) Three Months Ended
Mar 30, 2024 Dec 30, 2023 Apr 1, 2023
Americas $ 322  $ 334  $ 408 
Asia-Pacific 521  552  587 
Europe, Middle East and Africa 155  122  102 
Elimination of inter-segment sales (31) (25) (26)
Total Revenue $ 967  $ 983  $ 1,071 

Market Sectors ($ in millions) Three Months Ended
Mar 30, 2024 Dec 30, 2023 Apr 1, 2023
Healthcare/Life Sciences $ 379  39  % $ 381  39  % $ 488  46  %
Industrial 418  43  % 435  44  % 439  41  %
Aerospace/Defense 170  18  % 167  17  % 144  13  %
Total Revenue $ 967  $ 983  $ 1,071 

3


Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

ROIC and Economic Return
ROIC for the second quarter of fiscal 2024 was 9.9%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a three-quarter period for the second fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Our weighted average cost of capital for fiscal 2024 is 8.2%. ROIC for the second quarter of fiscal 2024 less our weighted average cost of capital resulted in an economic return of 1.7%.

Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended March 30, 2024, cash flows provided by operations were $87.8 million and capital expenditures were $22.9 million, which resulted in free cash flow of $64.9 million.

Cash Cycle Days Three Months Ended
Mar 30, 2024 Dec 30, 2023 Apr 1, 2023
Days in Accounts Receivable 61 61 56
Days in Contract Assets 12 12 11
Days in Inventory 158 161 156
Days in Accounts Payable (65) (66) (69)
Days in Advanced Payments (1) (75) (73) (72)
Annualized Cash Cycle (2) 91 95 82
(1) Includes a reclassification in the presentation of advanced payments from customers reflected in prior period amounts. As of April 1, 2023, the impact of this reclassification was an increase in the Company's days in advanced payments and a reduction in annualized cash cycle by 22 days.
(2) Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.


4


Conference Call and Webcast Information
What:
Plexus Fiscal 2024 Q2 Earnings Conference Call and Webcast
When:
Thursday, April 25, 2024 at 8:30 a.m. Eastern Time
Where:
Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:

Audio conferencing link:
https://register.vevent.com/register/BI408fb95be3e440b981d3e0808adddf91
Webcast link:
https://edge.media-server.com/mmc/p/wrgz2xex
Replay:
The webcast will be archived on the Plexus website and will be available as on-demand for 12 months
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
Since 1979, Plexus has been partnering with companies to create the products that build a better world. We are a team of over 20,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Sustaining Services. Plexus is a global leader that specializes in serving customers in industries with highly complex products and demanding regulatory environments. Plexus delivers customer service excellence to leading companies by providing innovative, comprehensive solutions throughout a product’s lifecycle. For more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2023 Form 10-K.
5


PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended Six Months Ended
Mar 30, Apr 1, Mar 30, Apr 1,
2024 2023 2024 2023
Net sales $ 966,900  $ 1,070,823  $ 1,949,507  $ 2,164,748 
Cost of sales 878,837  967,830  1,773,304  1,960,556 
Gross profit 88,063  102,993  176,203  204,192 
Operating expenses:
Selling and administrative expenses 47,555  46,051  90,537  89,909 
Restructuring and other charges, net 11,038  —  11,038  — 
Operating income 29,470  56,942  74,628  114,283 
Other income (expense):
Interest expense (8,293) (8,287) (15,910) (15,181)
Interest income 817  759  1,625  1,693 
Miscellaneous, net (3,027) (1,612) (6,529) (3,556)
Income before income taxes 18,967  47,802  53,814  97,239 
Income tax expense 2,728  6,958  8,360  14,205 
Net income
$ 16,239  $ 40,844  $ 45,454  $ 83,034 
Earnings per share:
Basic $ 0.59  $ 1.48  $ 1.65  $ 3.00 
Diluted $ 0.58  $ 1.45  $ 1.62  $ 2.94 
Weighted average shares outstanding:
Basic 27,542  27,661  27,513  27,650 
Diluted 27,929  28,184  27,982  28,273 


6


PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
(unaudited)
Mar 30, Sep 30,
2024 2023
ASSETS
Current assets:
Cash and cash equivalents $ 265,053  $ 256,233 
Restricted cash 41  421 
Accounts receivable 645,523  661,542 
Contract assets 131,174  142,297 
Inventories 1,518,729  1,562,037 
Prepaid expenses and other 70,531  49,693 
Total current assets 2,631,051  2,672,223 
Property, plant and equipment, net 493,803  492,036 
Operating lease right-of-use assets 63,106  69,363 
Deferred income taxes 62,665  62,590 
Other assets 26,032  24,960 
Total non-current assets 645,606  648,949 
Total assets $ 3,276,657  $ 3,321,172 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations $ 245,964  $ 240,205 
Accounts payable 627,427  646,610 
Advanced payments from customers 716,172  760,351 
Accrued salaries and wages 72,880  94,099 
Other accrued liabilities 74,392  71,402 
Total current liabilities 1,736,835  1,812,667 
Long-term debt and finance lease obligations, net of current portion 192,025  190,853 
Accrued income taxes payable 17,198  31,382 
Long-term operating lease liabilities 33,915  38,552 
Deferred income taxes 4,429  4,350 
Other liabilities 32,493  28,986 
Total non-current liabilities 280,060  294,123 
Total liabilities 2,016,895  2,106,790 
Shareholders’ equity:
Common stock 545  543 
Additional paid-in-capital 663,130  661,270 
Common stock held in treasury (1,151,997) (1,134,429)
Retained earnings 1,756,782  1,711,328 
Accumulated other comprehensive loss (8,698) (24,330)
Total shareholders’ equity 1,259,762  1,214,382 
Total liabilities and shareholders’ equity $ 3,276,657  $ 3,321,172 

7


PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 1
(in thousands, except per share data)
(unaudited)
Three Months Ended Six Months Ended
Mar 30, Dec 30, Apr 1, Mar 30, Apr 1,
2024 2023 2023 2024 2023
Operating income, as reported $ 29,470  $ 45,158  $ 56,942  $ 74,628  $ 114,283
Operating margin, as reported 3.0  % 4.6  % 5.3  % 3.8  % 5.3  %
Non-GAAP adjustments:
Restructuring costs (1) 13,288  —  —  13,288  — 
Other non-recurring income (2) (2,250) —  —  (2,250) — 
Non-GAAP operating income $ 40,508  $ 45,158  $ 56,942  $ 85,666  $ 114,283
Non-GAAP operating margin 4.2  % 4.6  % 5.3  % 4.4  % 5.3  %
Net income, as reported $ 16,239  $ 29,215  $ 40,844  $ 45,454  $ 83,034 
Non-GAAP adjustments:
Restructuring costs, net of tax (1) 11,893  —  —  11,893  — 
Other non-recurring income, net of tax (2) (2,014) —  —  (2,014) — 
Adjusted net income $ 26,118  $ 29,215  $ 40,844  $ 55,333  $ 83,034 
Diluted earnings per share, as reported $ 0.58  $ 1.04  $ 1.45  $ 1.62  $ 2.94 
Non-GAAP per share adjustments:
Restructuring costs, net of tax (1) 0.43  —  —  0.43  — 
Other non-recurring income, net of tax (2) (0.07) —  —  (0.07) — 
Adjusted diluted earnings per share $ 0.94  $ 1.04  $ 1.45  $ 1.98  $ 2.94 
(1) During the three and six months ended March 30, 2024, restructuring and impairment charges of $13.3 million, or $11.9 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region.
(2) During the three and six months ended March 30, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.
8


PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 2
 (in thousands)
(unaudited)
ROIC and Economic Return Calculations Six Months Ended Three Months Ended Six Months Ended
Mar 30, Dec 30, Apr 1,
2024 2023 2023
Operating income, as reported $ 74,628  $ 45,158  $ 114,283 
Restructuring and other charges, net + 11,038  + —  + — 
Adjusted operating income $ 85,666  $ 45,158  $ 114,283 
x 2 x 4 x 2
Adjusted annualized operating income $ 171,332  $ 180,632  $ 228,566 
Adjusted effective tax rate x 15  % x 16  % x 15  %
Tax impact 25,700  28,901  34,285 
Adjusted operating income (tax-effected) $ 145,632  $ 151,731  $ 194,281 
Average invested capital ÷ $ 1,478,062  ÷ $ 1,479,647  ÷ $ 1,406,359 
ROIC 9.9  % 10.3  % 13.8  %
Weighted average cost of capital - 8.2  % - 8.2  % - 9.0  %
Economic return 1.7  % 2.1  % 4.8  %
Average Invested Capital Calculations Mar 30, Dec 30, Sep 30, Jul 1, Apr 1, Dec 31, Oct 1,
2024 2023 2023 2023 2023 2022 2022
Equity $ 1,259,762  $ 1,266,755  $ 1,214,382  $ 1,184,362  $ 1,182,382  $ 1,150,259  $ 1,095,731 
Plus:
Debt and finance lease obligations - current 245,964  251,119  240,205  304,781  294,011  329,076  273,971 
Operating lease obligations - current (1) 8,281  9,172  8,363  8,772  8,358  8,878  7,948 
Debt and finance lease obligations - long-term
192,025  192,118  190,853  187,468  188,730  187,272  187,776 
Operating lease obligations - long-term 33,915  35,989  38,552  40,515  31,257  32,149  33,628 
Less:
Cash and cash equivalents (265,053) (231,982) (256,233) (252,965) (269,664) (247,880) (274,805)
$ 1,474,894  $ 1,523,171  $ 1,436,122  $ 1,472,933  $ 1,435,074  $ 1,459,754  $ 1,324,249 

(1) Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.








9


PLEXUS CORP. AND SUBSIDIARIES
NON-GAAP SUPPLEMENTAL INFORMATION Table 3
(in thousands, except per share data)
(unaudited)
Three Months Ended
Dec 31, Apr 1, Jul 1, Sep 30, Dec 30, Mar 30,
2022 2023 2023 2023 2023 2024
Net sales $ 1,093,925 $ 1,070,823 $ 1,021,610 $ 1,023,947 $ 982,607 $ 966,900
  Operating income, as reported 57,341 56,942 28,204 53,333 45,158 29,470
Operating margin, as reported 5.2  % 5.3  % 2.8  % 5.2  % 4.6  % 3.0  %
Non-GAAP adjustments:
Restructuring costs —  —  8,865  —  —  13,288 
Other non-recurring charges, net of tax —  —  14,229  —  —  (2,250)
Non-GAAP operating income, previously reported 57,341  56,942  51,298  53,333  45,158  40,508 
Non-GAAP operating margin, previously reported 5.2  % 5.3  % 5.0  % 5.2  % 4.6  % 4.2  %
Stock-based compensation 5,819  5,907  3,829  5,824  5,335  7,096 
Non-GAAP operating income $ 63,160 $ 62,849 $ 55,127 $ 59,157 $ 50,493 $ 47,604
Non-GAAP operating margin 5.8  % 5.9  % 5.4  % 5.8  % 5.1  % 4.9  %
Net income, as reported $ 42,190  $ 40,844  $ 15,799  $ 40,261  $ 29,215  $ 16,239 
Non-GAAP adjustments:
Restructuring costs, net of tax —  —  7,920  —  —  11,893 
Other non-recurring charges, net of tax —  —  13,346  —  —  (2,014)
Adjusted net income, previously reported 42,190  40,844  37,065  40,261  29,215  26,118 
Stock-based compensation 5,819  5,907  3,829  5,824  5,335  7,096 
Adjusted net income $ 48,009 $ 46,751 $ 40,894 $ 46,085 $ 34,550 $ 33,214
Diluted weighted average shares outstanding 28,305  28,184  27,992  27,972  28,013  27,929 
Diluted earnings per share, as previously reported $ 1.49  $ 1.45  $ 0.56  $ 1.44  $ 1.04  $ 0.58 
Non-GAAP per share adjustments:
Restructuring costs, net of tax —  —  0.28  —  —  0.43 
Other non-recurring charges, net of tax —  —  0.48  —  —  (0.07)
Adjusted diluted earnings per share, previously reported 1.49  1.45  1.32  1.44  1.04  0.94 
Stock-based compensation 0.21  0.21  0.14  0.21  0.19  0.25 
Adjusted diluted earnings per share $ 1.70  $ 1.66  $ 1.46  $ 1.65  $ 1.23  $ 1.19 
10